CVM Innovations in 2022

Published 6/22/2023

MU College of Veterinary Medicine researchers made discoveries and generated innovations in myriad areas in 2022 thanks in part to a unique combination of resources and disciplines at Missouri’s largest public research university. Researchers who believe they have an innovation with commercial potential report their inventions to the Office of Technology and Advancement, which evaluates each invention for novelty, utility and market potential after discussions with contributors. The office conducts an analysis of scientific and patent literature, potential competitors and other factors.

CVM Innovators with Patents, Commercial Agreements, Startup Companies and First Product Sales

Faculty, staff and students generate early-stage innovations that can be further developed in commercial settings for the benefit of society. The following innovators had patents, commercial agreements, startup companies and first product sales in 2022:

  • Joan R. Coates, Professor of Veterinary Medicine Neurology and Neurosurgery
    • Technology licensed by a commercial partner: DNA test for canine degenerative myelopathy.
    • First sales of a product that uses MU technology: FluoroKennel, a videofluoroscopic imaging system for companion animals to diagnose and track swallowing disorders.
    • First sales of a product that uses MU technology: Animaline, a canine degenerative myelopathy diagnostic test for dogs that detects changes in the animal’s superoxide dismutase 1 (SOD1) gene.
  • Gary S. Johnson, Associate Professor of Veterinary Pathobiology
    • Technology licensed by a commercial partner: DNA test for canine degenerative myelopathy.
    • First sales of a product that uses MU technology: Animaline, a canine degenerative myelopathy diagnostic test for dogs that detects changes in the animal’s superoxide dismutase 1 (SOD1) gene.
  • Chris Lorson, Associate Vice Chancellor for Research; Curators’ Distinguished Professor; College of Veterinary Medicine Associate Dean for Research and Graduate Studies
    • First sales of a product that uses MU technology: A monoclonal antibody that detects the human survival motor neuron protein responsible for spinal muscular atrophy.
  • George C. Stewart, Professor Emeritus of Veterinary Pathobiology
    • Patent No. 11,401,498: Bacillus-based delivery system

This bacterial platform for enzyme expression delivers enzymes for advances in agriculture, bioremediation, biofuel production and other applications.

  • Jonathan Williams, Doctoral Student, Pathobiology
    • Patent No. 11,241,353: Knee flexion device

A quantitative patient-controlled physical therapy device that can be used to treat pre- or post-surgery knee stiffness.

  • Shuping Zhang, Professor of Veterinary Pathobiology; Director of the Veterinary Medical Diagnostic Laboratory
    • Patent No. 11,422,134: High-sensitivity impedance sensor

This biosensor array enables rapid detection and quantification of bacteria and other analytes at low concentrations to detect toxins, prevent food-borne diseases and more.

MU Innovators Who Disclosed Inventions in 2021

University of Missouri researchers who think they have an innovation with commercial potential submit a confidential Invention Disclosure Form to the Office of Technology Advancement team. This information helps the team evaluate inventions for novelty, utility and market potential. Mizzou researchers disclose more than 100 new inventions every year.

  • Kamlendra Singh, Associate Research Professor of Veterinary Pathobiology; Assistant Director, Molecular Interactions Core